Zobrazeno 1 - 6
of 6
pro vyhledávání: '"June Fortin"'
Publikováno v:
BMC Geriatrics, Vol 24, Iss 1, Pp 1-10 (2024)
Abstract Background Encouraging compliance with recommended levels of exercise for older adults is a public health challenge. A minimal-resource solution is telephone coaching. Objectives Primary aim: to compare timed up and go (TUG) performance 6 mo
Externí odkaz:
https://doaj.org/article/e5b958a50bd544d3a0246f778ff0153f
Autor:
Jean-Baptiste Ducloyer, Juliette Ivan, Alexandra Poinas, Olivier Lebreton, Alexandre Bonissent, Paul Fossum, Christelle Volteau, Ramin Tadayoni, Catherine Creuzot-Garchet, Yannick Le Mer, Julien Perol, June Fortin, Anne Chiffoleau, Fanny Billaud, Catherine Ivan, Michel Weber
Publikováno v:
Trials, Vol 21, Iss 1, Pp 1-12 (2020)
Abstract Background The epiretinal membrane (ERM) is a degenerative condition associated with age, which can cause loss of vision and/or metamorphopsia. The treatment of symptomatic ERM involves surgical removal including a vitrectomy followed by pee
Externí odkaz:
https://doaj.org/article/24d128ce966748ad86a9a567846d62f8
Autor:
Catherine Ivan, June Fortin, Olivier Lebreton, Alexandra Poinas, Alexandre Bonissent, Michel Weber, Julien Perol, Juliette Ivan, Ramin Tadayoni, Paul Fossum, Anne Chiffoleau, Yannick Le Mer, Catherine Creuzot-Garchet, J.-B. Ducloyer, Christelle Volteau, Fanny Billaud
Publikováno v:
Trials
Trials, Vol 21, Iss 1, Pp 1-12 (2020)
Trials, Vol 21, Iss 1, Pp 1-12 (2020)
Background The epiretinal membrane (ERM) is a degenerative condition associated with age, which can cause loss of vision and/or metamorphopsia. The treatment of symptomatic ERM involves surgical removal including a vitrectomy followed by peeling of t
Autor:
Pierre Valrivière, Elisabeth Auffray-Calvier, Annabelle Bonnin-Rivalland, Anne Pichot, Véronique Sébille, Edouard Laforgue, Samuel Bulteau, Anne Sauvaget, Guillemette Fayet, Thibault Deschamps, Véronique Thomas-Ollivier, June Fortin, Jean-Marie Vanelle, Yann Péréon
Publikováno v:
Trials
Trials, 2017, 18 (1), pp.17. ⟨10.1186/s13063-016-1764-8⟩
Trials, 2017, 18 (1), pp.17. ⟨10.1186/s13063-016-1764-8⟩
Background The treatment of depression remains a challenge since at least 40% of patients do not respond to initial antidepressant therapy and 20% present chronic symptoms (more than 2 years despite standard treatment administered correctly). Repetit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::77dd4974363df889f4ea03001ac412e4
https://hal.archives-ouvertes.fr/hal-03158125
https://hal.archives-ouvertes.fr/hal-03158125
Autor:
June Fortin, Michel Attal, Cyrille Touzeau, Thierry Facon, Xavier Leleu, Anne Chiffoleau, Lucie Planche, Mourad Tiab, Hervé Avet-Loiseau, Murielle Roussel, Denis Caillot, Philippe Moreau, Brigitte Kolb, Carine Chaleteix, Jean-Yves Mary, Lotfi Benboubker, Cyrille Hulin
Publikováno v:
Blood. 125(20)
This phase 1/2 dose-escalation study investigated the combination of carfilzomib with melphalan and prednisone (CMP) in patients aged65 years with newly diagnosed multiple myeloma (MM). Melphalan and prednisone were administered orally on days 1 to 4
Publikováno v:
Journal of pharmaceutical and biomedical analysis. 44(1)
The target of this research was to evaluate the photostability of various sunscreen agents incorporated into an O/W emulsion. The concept of photostability is very important in the field of solar protection. The effectiveness of the anti-solar produc